These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 10733557

  • 1. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids.
    Marschall HU, Oppermann UC, Svensson S, Nordling E, Persson B, Höög JO, Jörnvall H.
    Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557
    [Abstract] [Full Text] [Related]

  • 2. 3 alpha-hydroxysteroid dehydrogenase activity of the Y' bile acid binders in rat liver cytosol. Identification, kinetics, and physiologic significance.
    Stolz A, Takikawa H, Sugiyama Y, Kuhlenkamp J, Kaplowitz N.
    J Clin Invest; 1987 Feb; 79(2):427-34. PubMed ID: 3468121
    [Abstract] [Full Text] [Related]

  • 3. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats.
    Takikawa H, Sugiyama Y, Fernandez-Checa JC, Kuhlenkamp J, Ookhtens M, Kaplowitz N.
    Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188
    [Abstract] [Full Text] [Related]

  • 4. Baboon alcohol dehydrogenase isozymes: purification and properties of liver class I ADH. Moderate alcohol consumption reduces liver class I and class II ADH activities.
    Holmes RS, Meyer J, VandeBerg JL.
    Prog Clin Biol Res; 1990 Jun; 344():819-41. PubMed ID: 2392481
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of 3 alpha(17 beta)-hydroxysteroid dehydrogenase distinct from 3 alpha-hydroxysteroid dehydrogenase in hamster liver.
    Ohmura M, Hara A, Nakagawa M, Sawada H.
    Biochem J; 1990 Mar 01; 266(2):583-9. PubMed ID: 2317205
    [Abstract] [Full Text] [Related]

  • 6. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
    Steckelbroeck S, Oyesanmi B, Jin Y, Lee SH, Kloosterboer HJ, Penning TM.
    J Pharmacol Exp Ther; 2006 Mar 01; 316(3):1300-9. PubMed ID: 16339391
    [Abstract] [Full Text] [Related]

  • 7. Measurement of bile acid in serum and bile with arylamine-glass-bound 3alpha-hydroxysteroid dehydrogenase and diaphorase.
    Rani K, Garg P, Pundir CS.
    Anal Biochem; 2004 Sep 01; 332(1):32-7. PubMed ID: 15301946
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.
    Ishikura S, Matsumoto K, Sanai M, Horie K, Matsunaga T, Tajima K, El-Kabbani O, Hara A.
    J Biochem; 2006 Jun 01; 139(6):1053-63. PubMed ID: 16788056
    [Abstract] [Full Text] [Related]

  • 9. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
    Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ, Penning TM.
    Mol Pharmacol; 2004 Dec 01; 66(6):1702-11. PubMed ID: 15383625
    [Abstract] [Full Text] [Related]

  • 10. Baboon alcohol dehydrogenase isozymes: phenotypic changes in liver following chronic consumption of alcohol.
    Holmes RS, VandeBerg JL.
    Isozymes Curr Top Biol Med Res; 1987 Dec 01; 16():1-20. PubMed ID: 3610585
    [Abstract] [Full Text] [Related]

  • 11. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency.
    Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzić N.
    J Pediatr Gastroenterol Nutr; 2010 Jan 01; 50(1):61-6. PubMed ID: 19915491
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the newly identified bile acid binder and bile acid oxidoreductases in human liver.
    Takikawa H, Stolz A, Sugiyama Y, Yoshida H, Yamanaka M, Kaplowitz N.
    J Biol Chem; 1990 Feb 05; 265(4):2132-6. PubMed ID: 2153675
    [Abstract] [Full Text] [Related]

  • 13. Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol.
    Itoh K, Hoshino K, Endo A, Asakawa T, Yamakami K, Noji C, Kosaka T, Tanaka Y.
    Chirality; 2006 Sep 05; 18(9):698-706. PubMed ID: 16823812
    [Abstract] [Full Text] [Related]

  • 14. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Beuers U, Fischer S, Spengler U, Paumgartner G.
    J Hepatol; 1991 Jul 05; 13(1):97-103. PubMed ID: 1918882
    [Abstract] [Full Text] [Related]

  • 15. Study of human isoursodeoxycholic acid metabolism.
    Marschall HU, Roeb E, Yildiz Y, Busch N, Nguyen H, Purucker E, Thomas HG, Matern S.
    J Hepatol; 1997 Apr 05; 26(4):863-70. PubMed ID: 9126801
    [Abstract] [Full Text] [Related]

  • 16. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.
    Gonzales E, Gerhardt MF, Fabre M, Setchell KD, Davit-Spraul A, Vincent I, Heubi JE, Bernard O, Jacquemin E.
    Gastroenterology; 2009 Oct 05; 137(4):1310-1320.e1-3. PubMed ID: 19622360
    [Abstract] [Full Text] [Related]

  • 17. In vitro studies of human liver alcohol dehydrogenase variants using a variety of substrates.
    Kassam JP, Tang BK, Kadar D, Kalow W.
    Drug Metab Dispos; 1989 Oct 05; 17(5):567-72. PubMed ID: 2573502
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of alcohol dehydrogenases of certain aerobic bacteria representing human colonic flora.
    Nosova T, Jousimies-Somer H, Kaihovaara P, Jokelainen K, Heine R, Salaspuro M.
    Alcohol Clin Exp Res; 1997 May 05; 21(3):489-94. PubMed ID: 9161610
    [Abstract] [Full Text] [Related]

  • 19. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E, Marschall HU, Winograd R, Matern S.
    Biochim Biophys Acta; 2001 Apr 03; 1526(1):44-52. PubMed ID: 11287121
    [Abstract] [Full Text] [Related]

  • 20. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
    Marschall HU, Broomé U, Einarsson C, Alvelius G, Thomas HG, Matern S.
    J Lipid Res; 2001 May 03; 42(5):735-42. PubMed ID: 11352980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.